Online citations, reference lists, and bibliographies.

Is There Any Association Between Myocardial Infarction, Gastro-oesophageal Reflux Disease And Acid-suppressing Drugs?

S. Johansson, M. Wallander, A. Ruigómez, L. Garcia Rodriguez
Published 2003 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND A link between gastro-oesophageal reflux disease and coronary heart disease has been suggested. AIM To estimate the incidence of myocardial infarction in patients with newly diagnosed gastro-oesophageal reflux disease in comparison with that in the general population. METHODS A population-based cohort study was performed in the UK. Patients aged 18-79 years with a first diagnosis of gastro-oesophageal reflux disease (n = 7084) were identified and a group of 10,000 patients free of gastro-oesophageal reflux disease were sampled. A nested case-control analysis was performed to assess the risk factors for myocardial infarction. RESULTS The incidence of myocardial infarction in the general population was 4.0 per 1,000 person-years [95% confidence interval (CI), 3.2-4.9] and 5.1 per 1,000 person-years (95% CI, 4.1-6.4) in patients with gastro-oesophageal reflux disease. The relative risk of myocardial infarction in patients with gastro-oesophageal reflux disease was 1.4 (95% CI, 1.0-1.9). The increased risk of myocardial infarction was limited to the immediate days after the diagnosis of gastro-oesophageal reflux disease. Previous chest pain was an important predictor of myocardial infarction in patients free of gastro-oesophageal reflux disease. No association was found between the use of acid-suppressing drugs and the risk of myocardial infarction. CONCLUSION Our results suggest that gastro-oesophageal reflux disease is not an independent predictor of myocardial infarction. Rather, the increased risk of myocardial infarction in patients with gastro-oesophageal reflux disease in the immediate days after diagnosis indicates that prodromal ischaemic symptoms were misinterpreted as reflux symptoms.
This paper references
10.1016/0140-6736(92)90599-X
Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men
Chris Isles (1992)
Effect of oesophageal acid
J Med (1962)
10.1016/S0002-9149(01)01841-0
Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria.
H. Koukkunen (2001)
Use of the UK General Practice Research Database for pharmacoepidemiology.
L. Garcia Rodriguez (1998)
10.1016/0140-6736(93)90817-Z
Effect of oesophageal acid instillation on coronary blood flow
A. Chauhan (1993)
Further validation
H Jick (1996)
10.1002/pds.2630010607
Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom
H. Jick (1992)
Reflux disease: the disorder of the third millennium.
G. Holtmann (2001)
Oesophageal reflux.
Peter I. Reed (1980)
10.1592/phco.23.5.686.32205
Validity of the general practice research database.
S. Jick (2003)
10.1097/00042737-199610000-00007
Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter?
Ashish J. Mehta (1996)
10.1136/bmj.2.5317.1425
Episodic, Postural, and Linked Angina
K. S. Smith (1962)
10.1111/j.0954-6820.1978.tb08420.x
Oesophageal function and coronary angiogram in patients with disabling chest pain.
Olle Svensson (1978)
10.1093/oxfordjournals.eurheartj.a014873
Cardio-oesophageal reflex in humans as a mechanism for "linked angina'.
Anoop J Chauhan (1996)
10.1159/000200911
Epidemiology and natural history of gastro-oesophageal reflux disease.
S. Spechler (1992)
10.1001/archinte.1990.00390170027007
The prevalence of abnormal esophageal test results in patients with cardiovascular disease and unexplained chest pain.
Edward G. Hewson (1990)
10.1016/S0016-5085(97)70025-8
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.
G. Locke (1997)



This paper is referenced by
10.3748/WJG.15.1764
Prevalence of linked angina and gastroesophageal reflux disease in general practice.
Hirohito Kato (2009)
10.1111/j.1572-0241.2005.00340.x
Mortality Associated with Barrett's Esophagus and Gastroesophageal Reflux Disease Diagnoses—A Population-Based Cohort Study
M. Solaymani-Dodaran (2005)
10.1111/dote.12329
Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain.
Sha Sha He (2016)
10.1097/MD.0000000000004089
Association between gastroesophageal reflux disease and coronary heart disease
Chien-hua Chen (2016)
10.1097/MEG.0b013e3283595086
Temporal trends of Barrett’s oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study
Kalliopi Alexandropoulou (2013)
10.1111/j.1365-2036.2008.03901.x
Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database.
H. El-Serag (2009)
10.1136/bmj.f2350
Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
E. Herrett (2013)
10.1111/j.1365-2362.2012.02696.x
Proton pump inhibitors prescribing following the introduction of generic drugs.
Simona Cammarota (2012)
A nationwide population-based analysis
Chien-Hua Chen (2016)
10.1159/000235919
Large Waist Circumference Is a Risk Factor for Reflux Esophagitis in Japanese Males
Hisae Yasuhara (2010)
10.1080/10408444.2019.1583167
Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents
Nawal Farhat (2019)
10.2169/INTERNALMEDICINE.52.0031
Acid reflux in patients with coronary artery disease and refractory chest pain.
Yijun Liu (2013)
Gender, Smoking and Blood Pressure and the Initial Presentation of a Wide Range of Cardiovascular Diseases: Prospective Cohort Study in 1.5 Million Patients Using Linked Electronic Health Records
Jennifer L. George (2013)
10.1136/pgmj.2004.029074
The heart and the oesophagus: intimate relations
Michael Heatley (2005)
10.1007/s40278-017-24883-6
Proton pump inhibitors
Vasudevan G. Naidoo (2016)
10.1371/journal.pone.0173899
Risk of acute myocardial infarction in patients with gastroesophageal reflux disease: A nationwide population-based study
W. Lei (2017)
10.22416/1382-4376-2019-29-4-66-73
Гастроэзофагеальная рефлюксная болезнь и ишемическая болезнь сердца — существует ли синдром взаимного отягощения?
Ольга Петровна Алексеева (2019)
10.1185/030079906X120986
Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care
Ana Ruigómez (2006)
10.1093/fampra/cmi061
Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease.
A. Hungin (2005)
10.1378/chest.08-0902
Relationship between gastroesophageal reflux disease and COPD in UK primary care.
L. Garcia Rodriguez (2008)
Hip Fracture Long-term Proton Pump Inhibitor Therapy and Risk of Correction
Y. Yang (2006)
10.1592/phco.30.10.985
Increased use of acid-suppressing drugs before the occurrence of ischemic events: a potential source of confounding in recent observational studies.
David F Blackburn (2010)
10.1111/j.1442-2050.2007.00768.x
Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database.
Ana Ruigómez (2008)
10.1080/00365520600884130
Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data
Mark van Blankenstein (2007)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
Semantic Scholar Logo Some data provided by SemanticScholar